* Immune Response Corp., of Carlsbad, Calif., named Dennis Carloas president and CEO. Carlo, a co-founder of the company, hasbeen responsible for research and development activities.* GalaGen Inc., of Arden Hills, Minn., appointed Robert Hoerr asits president and CEO. Hoerr has been interim president sinceFebruary.* Genetics Institute Inc., of Cambridge, Mass., appointed Neil Kirbyto director of international regulatory affairs, and Richard Crout toits board of directors.* Sepracor Inc., of Marlborough, Mass., appointed NallagounderKuppusamy as vice president of manufacturing of Sepracor CanadaLtd.* COR Therapeutics Inc., of South San Francisco, appointed ShaunCoughlin to its board of directors.* Biomira Inc., of Edmonton, Alberta, appointed S. Stewart Siddallto its board of directors.* Ingenex Inc., of Menlo Park, Calif., appointed Wilhelm Schaefflerto a new seat on its board of directors.* LifeCell Corp. of The Woodlands, Texas, promoted AnthonyBrown to vice president and chief financial officer, and electedDennis Sellke to its board of directors.* GenVec Inc., of Rockville, Md., appointed Mark Roffman to vicepresident of development, a new position.* Texas Biotechnology Corp., of Houston, appointed EdwardMaggio and Patrick Burns to its board of directors.* Genetic Therapy Inc., of Gaithersburg, Md., hired VictorSantamarina as vice president of operations.* BioCryst Pharmaceuticals Inc., of Birmingham, Ala., appointedWilliam Cook to the new position of vice president of medicalaffairs.* Alan Bernstein was appointed as director of the Samuel LunenfeldResearch Institute of Mount Sinai Hospital of Toronto.* ImmuCell Corp., of Portland, Maine, appointed Mitchel Sayare toits board of directors.* Ariad Pharmaceuticals Inc., of Cambridge, Mass., appointedMichael Gilman as vice president, research in charge of genetherapy programs.* Receptagen Corp., of Seattle, a subsidiary of Receptagen Ltd.,appointed Scott Graves as head of research management.* Feinstein Partners Inc., of Cambridge, Mass., hired Leslie Krameras media relations manager, and Lisa Hanna-Valone as manager,emerging business group.* Bio-Research Laboratories Ltd., of Senneville, Quebec, appointedBruce Maloff as director, corporate development U.S.A.* Tanox Biosystems Inc., of Houston, promoted Eric Mirabel tovice president, intellectual property, and George Wang to vicepresident, process development and production.* CytoMed Inc., of Cambridge, Mass., appointed Peter Gund to itsscientific advisory board.* Orquest Inc., of Mountain View, Calif., appointed James Poser asvice president of research and development.
(c) 1997 American Health Consultants. All rights reserved.